Decision Diagnostics Forecast | Price, Price Target & Analyst Assessment

Decision Diagnostics

OTCPK:DECN

$ 0,00

$0,00 (0,00%)

0,00 $

$0,00 (0,00%)

End-of-day quote: 02/14/2024

Decision Diagnostics Stock Value

The current analyst recommendation for OTCPK:DECN is: sf_Data Unavailable.

Decision Diagnostics Company Info

EPS Growth 5Y

0,00%

Market Cap

$0,00 B

Long-Term Debt

$0,01 B

Short Interest

0,00%

Annual earnings

N/A

Dividend

$0,00

Dividend Yield

0,00%

Founded

2000

Industry

Health Care

Country

United States

ISIN Number

US2434431084

Website

http://www.decisiondiagnostics.co

Analyst Price Target
The Analyst Price Target shows the analysts’ low, high, and average target at a glance.

There are currently no price targets available for this stock.

In the last five quarters, Decision Diagnostics’s Price Target has risen from $0,00 to $0,00 - a 100,00% increase.

Top growth stocks in the health care sector (5Y.)

What does Decision Diagnostics do?

Decision Diagnostics Corp. engages in the distribution of prescription and non-prescription diagnostics and home testing products. The company’s subsidiaries, Pharma Tech Solutions, Inc., Pharmtech Direct Corp. and PDA Services, Inc. operate in healthcare products distribution channels. It distributes brand name prescription and non-prescription diagnostics products, as well as several lines of ostomy, wound care and post-surgery medical products. The company, through its PDA Services, Inc. an...

Decision Diagnostics Corp. engages in the distribution of prescription and non-prescription diagnostics and home testing products.

The company’s subsidiaries, Pharma Tech Solutions, Inc., Pharmtech Direct Corp. and PDA Services, Inc. operate in healthcare products distribution channels. It distributes brand name prescription and non-prescription diagnostics products, as well as several lines of ostomy, wound care and post-surgery medical products.

The company, through its PDA Services, Inc. and Decision IT Corp. subsidiaries, also offers information technology solutions in several medical care market channels by providing physicians with information at the point of care. Its products make use of smart cell phones such as the Apple iPhone, the Palm Pre, the Google Droid and a selection of Microsoft Windows based smart phones and operate in either in a wireless or ‘wired’ mode, which allow physicians to carry, access and update their patients’ histories, also known as electronic medical records or EMR/EHR, medication data, and best care guidelines - all at the point of care, or from any other location the physician may be located. The company has entered into eight partnerships with freestanding pharmacies in the states of New York, Texas, New Jersey and Arizona.

Prescription and Non-prescription Diagnostics Distribution

The company’s medical distribution business specializes in the distribution of medical diagnostic and medical disposable products associated with the on-going care of diabetes inflicted patients. Included in its business plan is the distribution of wound care, ostomy, and post-surgical products to diabetes-inflicted patients and other parallel markets. The company has also entered into a broad-based agreement with Shasta Technologies, LLC where it would have exclusive rights to the Shasta Genstrip diagnostic product.

Prescription and Non-prescription Diagnostics

The company owns a retail mail order business concept for the distribution of pharmaceutical and healthcare supplies. It focuses its distribution activities to patients who lack prescription drug coverage and patients who qualify for government or institutional programs, such as Medicare, Medicaid, children’s health insurance programs, and long-term care institutions and organizations.

The company’s retail prescription business maintains three operating units, including licensed wholesale prescription drug distribution business, where it delivers bulk prescription drugs on a wholesale basis to clients; licensed distribution of diabetes diagnostics and supplies, where it delivers diabetic testing strips and associated diagnostic products under various business models; and Internet pharmacy/prescription fulfillment.

Medical Field Applications

The company’s medical technologies are grounded in the central need/desire to furnish the practicing physician with point-of-care patient information and historical patient medical information using electronic medical records through a smart cell phone.

Regulations

As a distributor of drugs, the company is subject to regulation by and licensure with the Food and Drug Administration (FDA), the Drug Enforcement Agency (DEA), and various state agencies that regulate wholesalers or distributors.

IT Patents, Proprietary Rights and Licenses

In 2010, the company filed a full utility patent application, Management and Communications System and Method, Serial No. 13,034,639. The patent application covers 104 separate processes and encompasses the method, system and apparatus of software technology and the integration of software technology into commercial computer networks through commercial smart cell phone devices.

History

The company was founded in 2000. It was formerly known as InstaCare Corp. and changed its name to Decision Diagnostics Corp. in 2011.

New support ticket

Explore

Decision Diagnostics Stock Value

Decision Diagnostics Company Info

Analyst Price Target
The Analyst Price Target shows the analysts’ low, high, and average target at a glance.

Top growth stocks in the health care sector (5Y.)

What does Decision Diagnostics do?

Offer & Services

Service & Collaboration

Company & Legal

New support ticket

Explore

Decision Diagnostics Stock Value

Decision Diagnostics Company Info

Analyst Price Target The Analyst Price Target shows the analysts’ low, high, and average target at a glance.

Top growth stocks in the health care sector (5Y.)

What does Decision Diagnostics do?

Offer & Services

Service & Collaboration

Company & Legal

Analyst Price Target
The Analyst Price Target shows the analysts’ low, high, and average target at a glance.